XETRA - Delayed Quote EUR

RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE)

12.90 0.00 (0.00%)
As of April 24 at 5:36 PM GMT+2. Market Open.
Loading Chart for RHK.DE
DELL
  • Previous Close 12.90
  • Open 13.10
  • Bid 12.70 x 15100
  • Ask 13.00 x 14500
  • Day's Range 12.90 - 13.10
  • 52 Week Range 9.50 - 14.00
  • Volume 105
  • Avg. Volume 4,131
  • Market Cap (intraday) 863.507M
  • Beta (5Y Monthly) -0.03
  • PE Ratio (TTM) 22.24
  • EPS (TTM) 0.58
  • Earnings Date May 9, 2024 - May 13, 2024
  • Forward Dividend & Yield 0.15 (1.16%)
  • Ex-Dividend Date Jun 8, 2023
  • 1y Target Est 13.80

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

www.rhoen-klinikum-ag.com

10,017

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RHK.DE

Performance Overview: RHK.DE

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RHK.DE
29.00%
DAX PERFORMANCE-INDEX
7.33%

1-Year Return

RHK.DE
4.01%
DAX PERFORMANCE-INDEX
13.34%

3-Year Return

RHK.DE
15.89%
DAX PERFORMANCE-INDEX
17.67%

5-Year Return

RHK.DE
49.51%
DAX PERFORMANCE-INDEX
46.02%

Compare To: RHK.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RHK.DE

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    863.51M

  • Enterprise Value

    660.56M

  • Trailing P/E

    22.24

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.59

  • Price/Book (mrq)

    0.69

  • Enterprise Value/Revenue

    0.45

  • Enterprise Value/EBITDA

    5.64

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.23%

  • Return on Assets (ttm)

    1.40%

  • Return on Equity (ttm)

    3.17%

  • Revenue (ttm)

    1.73B

  • Net Income Avi to Common (ttm)

    38.71M

  • Diluted EPS (ttm)

    0.58

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    342.84M

  • Total Debt/Equity (mrq)

    11.70%

  • Levered Free Cash Flow (ttm)

    22.36M

Research Analysis: RHK.DE

Analyst Price Targets

12.50 Low
13.80 Average
12.90 Current
15.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: RHK.DE

People Also Watch